speb/financial-data huggingface dataset:
Stock screener scorecard for CAST (quarterly, report date 2026-03-31)
Altman Z-score: -270.34339343275275 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -4245.179691956646%
Revenue growth: 49.636012240296346%
Rule of 40 score: -4195.543679716349
Market cap: 91831448 (Micro Cap ($50M-$300M))
Debt to equity: -0.775732486935114
Free cash flow (dilution adjusted): -3944154
Operating income: -4421866
Net income: -4533974
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CBNK (quarterly, report date 2026-03-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.4725106480011076%
Capitalized R&D asset: 0
Free cash flow margin: 33.591255619990875%
Revenue growth: -0.329593609455927%
Rule of 40 score: 33.26166201053495
Market cap: 588487424 (Small Cap ($300M-$2B))
P/E ratio: 8.924698795180722
Debt to equity: 0.1273348513790818
Free cash flow (dilution adjusted): 20621000
Net income: 12018000
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CHN.AX (annual, report date 2025-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -18.715325534315163%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -20.021959420820274%
Rule of 40 score: 0
Market cap: 421375552 (Small Cap ($300M-$2B))
Debt to equity: 0.014499999999999999
Free cash flow (dilution adjusted): -11758169.934640523
Operating income: -17162745.098039214
Net income: -15826143.790849673
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for CHN.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 421375552 (Small Cap ($300M-$2B))
Debt to equity: 0.014499999999999999
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CRSU.PA (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.9869570765151248%
Capitalized R&D asset: 0
Free cash flow margin: 24.130976083896993%
Revenue growth: 20.78186989473415%
Rule of 40 score: 44.91284597863114
Market cap: 1017482368 (Small Cap ($300M-$2B))
P/E ratio: 9.180556593666694
Debt to equity: 0.04624215398971109
Free cash flow (dilution adjusted): 120627058.82352942
Net income: 125977647.05882353
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CRSU.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1017482368 (Small Cap ($300M-$2B))
P/E ratio: 9.180556593666694
Debt to equity: 0.04624215398971109
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CVCB3.SA (quarterly, report date 2026-03-31)
Altman Z-score: -0.9385784854529888 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.1169005224145945%
Free cash flow margin: -24.845411037228406%
Revenue growth: 4.807008084752339%
Rule of 40 score: -20.038402952476066
Market cap: 635374272 (Small Cap ($300M-$2B))
Debt to equity: 1.3980000000000001
Free cash flow (dilution adjusted): -17844106.463878326
Operating income: 3678517.1102661598
Net income: -13749239.543726236
Long score: 0 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for DMO (annual, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.26074534846198%
Capitalized R&D asset: 0
Free cash flow margin: 82.90503811412722%
Revenue growth: -18.033749040042377%
Rule of 40 score: 64.87128907408484
Market cap: 119413488 (Micro Cap ($50M-$300M))
P/E ratio: 8.633333333333333
Debt to equity: 0.9229
Free cash flow (dilution adjusted): 11864186
Net income: 13697393
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DMO (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 119413488 (Micro Cap ($50M-$300M))
P/E ratio: 8.633333333333333
Debt to equity: 0.9229
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DRCT (quarterly, report date 2026-03-31)
Altman Z-score: -4.055847139375133 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -18.45808383233533%
Revenue growth: -20.551855375832538%
Rule of 40 score: -39.009939208167864
Market cap: 1885804 (Nano Cap (< $50M))
Debt to equity: -1.7971402119123547
Free cash flow (dilution adjusted): -1233000
Operating income: -3251000
Net income: -5250000
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for DX (quarterly, report date 2026-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2991419648 (Mid Cap ($2B-$10B))
P/E ratio: 4.134185303514377
Debt to equity: 7.1349
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ECX (quarterly, report date 2026-03-31)
Altman Z-score: -2.5111890064958766 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 68851849.92887625
Rosenberg metric: -1.2425474572934032
Revenue growth: -57.972719021259735%
Rule of 40 score: -57.972719021259735
Market cap: 392951584 (Small Cap ($300M-$2B))
Debt to equity: -2.0257791458253167
Operating income: -17105263.157894738
Net income: -13947368.421052631
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for ENRG.L (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.3429507289623586%
Capitalized R&D asset: 0
Free cash flow margin: 118.20862513822337%
Rule of 40 score: 118.20862513822337
Market cap: 290519712 (Micro Cap ($50M-$300M))
P/E ratio: 0.18425785550875637
Debt to equity: 0
Free cash flow (dilution adjusted): 26002702.702702705
Net income: 18287837.837837838
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ENRG.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 290519712 (Micro Cap ($50M-$300M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ESR.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 55813428 (Micro Cap ($50M-$300M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for FLD (quarterly, report date 2026-03-31)
Altman Z-score: -3.845361226423155 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -85.08278012231094%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -21.540270815026783%
Free cash flow margin: -156.4604575757267%
Revenue growth: -38.81977765951725%
Rule of 40 score: -195.28023523524396
Market cap: 22857586 (Nano Cap (< $50M))
Debt to equity: 0.8845000000000001
Free cash flow (dilution adjusted): -8756164
Operating income: -7830313
Net income: -29167906
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for FNTL.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 206302720 (Micro Cap ($50M-$300M))
P/E ratio: 0.45945945945945954
Debt to equity: 0.4611
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GEM.OL (annual, report date 2025-12-31)
Altman Z-score: 27.96204254896113 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -219.29871520342613%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -55.44704264099036%
Revenue growth: -100%
Rule of 40 score: -100
Market cap: 23231610 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -932636.815920398
Operating income: -401094.527363184
Net income: -463582.08955223876
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for HALEOSLABS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.4267337868441954 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.006654190060303%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.10431659381835293%
Revenue growth: -24.58141618631421%
Rule of 40 score: -24.58141618631421
Market cap: 4651024896 (Mid Cap ($2B-$10B))
P/E ratio: 0.22014065182797118
Debt to equity: 0.4815
Operating income: 32958.88088172954
Net income: 46174.226367104704
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for HALEOSLABS.NS (annual, report date 2026-03-31)
Altman Z-score: 2.2058042441684877 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -11.496696322023832%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.79710590213896%
Free cash flow margin: -6.183025783828074%
Revenue growth: -12.22120804434847%
Rule of 40 score: -18.404233828176544
Market cap: 4651024896 (Mid Cap ($2B-$10B))
P/E ratio: 0.22014065182797118
Debt to equity: 0.4815
Free cash flow (dilution adjusted): -2187219.1606612974
Operating income: 3095400.59347181
Net income: 1886424.3323442137
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for HPIL.NS (annual, report date 2026-03-31)
Altman Z-score: 4.091658670476502 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.4995176184131935%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8301180527060019%
Free cash flow margin: -8.14380063150045%
Revenue growth: 2.444113853838642%
Rule of 40 score: -5.6996867776618085
Market cap: 1435553664 (Small Cap ($300M-$2B))
P/E ratio: 0.5030948864036013
Debt to equity: 0.6018
Free cash flow (dilution adjusted): -993026.706231454
Operating income: 59601.5260703688
Net income: 291055.5320050869
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HPIL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 3.1194669086977234 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.002572701796297%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.208866794392275%
Revenue growth: 28.681163451678636%
Rule of 40 score: 28.681163451678636
Market cap: 1435553664 (Small Cap ($300M-$2B))
P/E ratio: 0.5030948864036013
Debt to equity: 0.6018
Operating income: -86795.25222551929
Net income: 219870.70792708776
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for HYPD (quarterly, report date 2026-03-31)
Altman Z-score: -2.8182314797845964 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 43.24010118152513%
Capitalized R&D asset: 536735.33
ROCI (R&D adjusted): -7.616905109572908%
Rosenberg metric: 2.7395144320839995
Free cash flow margin: -3059.7049997748404%
Revenue growth: 1238.379563043627%
Rule of 40 score: -1821.3254367312134
Market cap: 38045944 (Nano Cap (< $50M))
P/E ratio: 1.4788171310042928
Debt to equity: 0.0102
Free cash flow (dilution adjusted): -7473972
Operating income: -5040608
Net income: 8840550
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for MCF.V (quarterly, report date 2026-03-31)
Altman Z-score: -3.1836596031890316 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.1400412560165023%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.5723015703830026%
Rule of 40 score: 0
Market cap: 4645677 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -76258.9928057554
Operating income: -260431.654676259
Net income: -286330.9352517986
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MCN (quarterly, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 117254824 (Micro Cap ($50M-$300M))
P/E ratio: 17.870967741935484
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MFG (annual, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.620234093999867%
Capitalized R&D asset: 0
Free cash flow margin: -119.47141004962106%
Revenue growth: 6.079712169402409%
Rule of 40 score: -113.39169788021864
Market cap: 129496711168 (Large Cap ($10B-$200B))
P/E ratio: 12.806451612903226
Debt to equity: 2.295789156156363
Free cash flow (dilution adjusted): -32266541541.541542
Net income: 7846327577.577578
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for MFG (quarterly, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.2070350872653286%
Capitalized R&D asset: 0
Revenue growth: 20.7147928901695%
Rule of 40 score: 20.7147928901695
Market cap: 129496711168 (Large Cap ($10B-$200B))
P/E ratio: 12.806451612903226
Debt to equity: 2.295789156156363
Net income: 1440740740.7407408
Long score: 0 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for MYS.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 819715328 (Small Cap ($300M-$2B))
P/E ratio: 10.457516339869281
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NKL.V (quarterly, report date 2026-04-30)
Altman Z-score: 1.4810097453298185 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.5123238532663805%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.36018179496939506%
Rule of 40 score: 0
Market cap: 98965808 (Micro Cap ($50M-$300M))
P/E ratio: 30.900243309002434
Debt to equity: 0.39380000000000004
Free cash flow (dilution adjusted): -285957.6642335766
Operating income: -306896.35036496347
Net income: 1506132.116788321
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for NNNN (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 434522848 (Small Cap ($300M-$2B))
P/E ratio: 200.46666666666667
Debt to equity: 0
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for NWL.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5148422656 (Mid Cap ($2B-$10B))
P/E ratio: 94.03239556692242
Debt to equity: 0.0837
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for NWL.AX (annual, report date 2025-06-30)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 69.71058864305934%
Capitalized R&D asset: 0
Free cash flow margin: 38.08630273842765%
Revenue growth: 24.083092474754746%
Rule of 40 score: 62.1693952131824
Market cap: 5148422656 (Mid Cap ($2B-$10B))
P/E ratio: 94.03239556692242
Debt to equity: 0.0837
Free cash flow (dilution adjusted): 77739869.28104575
Net income: 76156862.74509804
Long score: 8 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PDN.TO (annual, report date 2025-06-30)
Altman Z-score: 5.695139761459716 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -5.307640901969287%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.8585866491864866%
Free cash flow margin: -29.593754924694387%
Rule of 40 score: -29.593754924694387
Market cap: 4411258880 (Mid Cap ($2B-$10B))
Debt to equity: 0.1858
Free cash flow (dilution adjusted): -34366666.666666664
Operating income: -25777124.183006536
Net income: -29175816.993464053
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for PDN.TO (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4411258880 (Mid Cap ($2B-$10B))
Debt to equity: 0.1858
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for QTI (quarterly, report date 2026-03-31)
Altman Z-score: -1.6962175411417137 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -89.57620426428007%
Capitalized R&D asset: 2867468.4600000004
ROCI (R&D adjusted): -11.773342577475228%
Rosenberg metric: -0.37803545137169936
Free cash flow margin: -62.052067381317%
Revenue growth: -21.08828082421055%
Rule of 40 score: -83.14034820552754
Market cap: 38139860 (Nano Cap (< $50M))
Debt to equity: 1.5278
Free cash flow (dilution adjusted): -4052000
Operating income: -2349000
Net income: -3406000
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for QUMS (quarterly, report date 2026-03-31)
Altman Z-score: 18.73395916524998 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.6890726364730396%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.21044167801430644%
Rule of 40 score: 0
Market cap: 112313800 (Micro Cap ($50M-$300M))
P/E ratio: 84.33333333333333
Debt to equity: 0
Free cash flow (dilution adjusted): -93266
Operating income: -178721
Net income: 562384
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for QUMS (annual, report date 2026-03-31)
Altman Z-score: 18.69919834585678 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.1985671488409098%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.2671951684217544%
Rule of 40 score: 0
Market cap: 112313800 (Micro Cap ($50M-$300M))
P/E ratio: 84.33333333333333
Debt to equity: 0
Free cash flow (dilution adjusted): -947443
Operating income: -1076186
Net income: 978206
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for SGA.AX (annual, report date 2024-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.440351292637473%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -13.541047631794797%
Rule of 40 score: 0
Market cap: 23567280 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -3487010
Operating income: -1972802
Net income: -2048509.3333333333
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for SHOE.L (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 28660636 (Nano Cap (< $50M))
Debt to equity: 1.1148
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SURAJEST.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.5967631690315087 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.2164613279619825%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.1567565068699497%
Revenue growth: -47.807698154309286%
Rule of 40 score: -47.807698154309286
Market cap: 9280411648 (Mid Cap ($2B-$10B))
P/E ratio: 0.09476205870586056
Debt to equity: 0.6498
Operating income: 5152501.05977109
Net income: 1140515.0487494702
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SURAJEST.NS (annual, report date 2026-03-31)
Altman Z-score: 2.1065288448587665 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.382615842110258%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.834916029328962%
Free cash flow margin: -4.646402535304157%
Revenue growth: -8.229432470559802%
Rule of 40 score: -12.875835005863959
Market cap: 9280411648 (Mid Cap ($2B-$10B))
P/E ratio: 0.09476205870586056
Debt to equity: 0.6498
Free cash flow (dilution adjusted): -2737134.3789741416
Operating income: 22581538.787621874
Net income: 9570305.21407376
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SYRE (quarterly, report date 2026-03-31)
Altman Z-score: 55.67930579322613 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -10.286802094777814%
Capitalized R&D asset: 105249970
ROCI (R&D adjusted): -8.332302668656036%
Rule of 40 score: 0
Market cap: 8869097472 (Mid Cap ($2B-$10B))
Debt to equity: 0
Free cash flow (dilution adjusted): -70178000
Operating income: -75641000
Net income: -69005000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for TBLD.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 37361764 (Nano Cap (< $50M))
Debt to equity: 0.002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TBLD.L (annual, report date 2025-12-31)
Altman Z-score: 1.319919792072727 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.164655784244145%
Free cash flow margin: 1.6839852440088985%
Revenue growth: 16.666666666666664%
Rule of 40 score: 18.350651910675563
Market cap: 37361764 (Nano Cap (< $50M))
Debt to equity: 0.002
Free cash flow (dilution adjusted): 598000
Operating income: -1467000
Net income: -3896000
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for TNG.PA (annual, report date 2025-12-31)
Altman Z-score: 6.729984747467618 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -30.43899873444768%
Capitalized R&D asset: 74649767.89215687
ROCI (R&D adjusted): -16.223508587830462%
Free cash flow margin: -7920.408163265306%
Revenue growth: 80.26441847097144%
Rule of 40 score: -7840.143744794334
Market cap: 210639392 (Micro Cap ($50M-$300M))
Debt to equity: 0.0169
Free cash flow (dilution adjusted): -45658823.52941176
Operating income: -39997647.05882353
Net income: -44145882.35294118
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for TNG.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 210639392 (Micro Cap ($50M-$300M))
Debt to equity: 0.0169
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TWO (quarterly, report date 2026-03-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.819650017554557%
Capitalized R&D asset: 0
Free cash flow margin: 59.64288628072588%
Revenue growth: 25.1571776581623%
Rule of 40 score: 84.80006393888819
Market cap: 1271060736 (Small Cap ($300M-$2B))
P/E ratio: 8.760911027211622
Debt to equity: 4.7918
Free cash flow (dilution adjusted): 51173000
Net income: 32284000
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for UJO.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5247058 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for UJO.L (annual, report date 2025-12-31)
Altman Z-score: 1.9174286086125636 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -45.94344619869853%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.607372256448958%
Free cash flow margin: -129.27467165185718%
Revenue growth: -31.51274011446818%
Rule of 40 score: -160.78741176632536
Market cap: 5247058 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -4349056.756756756
Operating income: -2413812.1621621624
Net income: -9499121.621621622
Long score: 3 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for WFC (quarterly, report date 2026-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 264124940288 (Mega Cap (>= $200B))
P/E ratio: 12.011627906976745
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1660.HK (annual, report date 2025-03-31)
Altman Z-score: 6.4363174236015865 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.718777669593932%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -13.424597246586126%
Free cash flow margin: 11.849984082789708%
Revenue growth: -25.596734864822608%
Rule of 40 score: -13.7467507820329
Market cap: 867300000 (Small Cap ($300M-$2B))
Debt to equity: 0.056336474866161876
Free cash flow (dilution adjusted): 3014267.35218509
Operating income: -5567480.719794344
Net income: -10000642.67352185
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 5105.T (annual, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: 11.074038152836586%
Revenue growth: 5.619641914429832%
Rule of 40 score: 16.693680067266417
Market cap: 658018629202.8724 (Mega Cap (>= $200B))
P/E ratio: 10.343927896420166
Free cash flow (dilution adjusted): 421213477.3991433
Operating income: 622402659.6764913
Net income: 406713125.75922257
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6699.T (annual, report date 2025-03-31)
Altman Z-score: 1.2706321080153604 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 25.720354636128555%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.798574251288212%
Free cash flow margin: 2.4028607561815885%
Revenue growth: -0.529555768320976%
Rule of 40 score: 1.8733049878606125
Market cap: 6297699548.88 (Mid Cap ($2B-$10B))
P/E ratio: 14.510828453640555
Debt to equity: 3.3307072980694317
Free cash flow (dilution adjusted): 14730650.982488971
Operating income: 15178452.078599118
Net income: 2900681.727041839
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ALGEC.PA (annual, report date 2025-03-31)
Altman Z-score: 1.0735908565662138 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.896339377352039%
Free cash flow margin: -14.645799011532127%
Revenue growth: -19.011242102121987%
Rule of 40 score: -33.65704111365412
Market cap: 4177114.11 (Nano Cap (< $50M))
Debt to equity: 0.6362552176505668
Free cash flow (dilution adjusted): -2898913.0434782607
Operating income: -692391.304347826
Net income: -916304.3478260869
Long score: 1 | Short score: 13
Recommendation: Short
Stock screener scorecard for ANRO (annual, report date 2025-12-31)
Altman Z-score: 9.539374130232176 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -41.41866589035477%
Capitalized R&D asset: 87102350
ROCI (R&D adjusted): -23.693527654020055%
Rule of 40 score: 0
Market cap: 624672132 (Small Cap ($300M-$2B))
Debt to equity: 0.15851318627515845
Free cash flow (dilution adjusted): -59901000
Operating income: -66364000
Net income: -63238000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for ARBB (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 15387383.500799999 (Nano Cap (< $50M))
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for BHM (annual, report date 2025-12-31)
Altman Z-score: 0.2540525099589032 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.295493292527804%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.8672025080519035%
Free cash flow margin: 8.052783193179504%
Revenue growth: 36.88214442187438%
Rule of 40 score: 44.93492761505388
Market cap: 42730971.62 (Nano Cap (< $50M))
P/E ratio: 18.991542942222225
Debt to equity: 0.6192067530064755
Free cash flow (dilution adjusted): 5535000
Operating income: -20917000
Net income: 2250000
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for BTBT (annual, report date 2025-12-31)
Altman Z-score: 1.5328058349240652 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -47.36734565958038%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.23449928493723%
Free cash flow margin: -527.8520631150036%
Revenue growth: 5.099086799236507%
Rule of 40 score: -522.7529763157671
Market cap: 667926000 (Small Cap ($300M-$2B))
Debt to equity: 0.15505914134776672
Free cash flow (dilution adjusted): -599430492
Operating income: -56609654
Net income: -80316584
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CBNK (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 16.250758274541088%
Capitalized R&D asset: 0
Free cash flow margin: 27.25599213901016%
Revenue growth: 31.278269152265615%
Rule of 40 score: 58.534261291275776
Market cap: 455414017.8 (Small Cap ($300M-$2B))
P/E ratio: 7.965961479797096
Debt to equity: 0.12958579439810633
Free cash flow (dilution adjusted): 65739000
Net income: 57170000
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for CVCB3.SA (annual, report date 2025-12-31)
Altman Z-score: -0.29228169138197774 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 24.635454908477293%
Free cash flow margin: 15.427415513542892%
Revenue growth: 18.149822817266827%
Rule of 40 score: 33.57723833080972
Market cap: 1106748424.854291 (Small Cap ($300M-$2B))
Debt to equity: 0.9672759095304643
Free cash flow (dilution adjusted): 41904379.56204379
Operating income: 41879014.59854014
Net income: -7469890.510948905
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for DRCT (annual, report date 2025-12-31)
Altman Z-score: -3.6807649706976915 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -30.160834726465673%
Revenue growth: -44.30066786539943%
Rule of 40 score: -74.4615025918651
Market cap: 10412596.48 (Nano Cap (< $50M))
Debt to equity: -1.847928235796668
Free cash flow (dilution adjusted): -10464000
Operating income: -14755000
Net income: -18946000
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for DX (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.044078656650465%
Capitalized R&D asset: 0
Free cash flow margin: 29.092238110466447%
Revenue growth: 147.4221388866725%
Rule of 40 score: 176.51437699713895
Market cap: 3043650800.38 (Mid Cap ($2B-$10B))
P/E ratio: 9.539251441331889
Debt to equity: 0
Free cash flow (dilution adjusted): 108256000
Net income: 319066000
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for ECX (annual, report date 2025-12-31)
Altman Z-score: -1.8205501540263995 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 387340563.3937735
ROCI (R&D adjusted): -61.20706951608997%
Rosenberg metric: 0.0814249776814971
Free cash flow margin: -14.141518980772725%
Revenue growth: 18.803318502617294%
Rule of 40 score: 4.66179952184457
Market cap: 441699724.1784 (Small Cap ($300M-$2B))
Debt to equity: -1.606272158038628
Free cash flow (dilution adjusted): -162027027.02702704
Operating income: -67532432.43243243
Net income: -89247297.2972973
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for FLD (annual, report date 2025-12-31)
Altman Z-score: -1.0929504271969452 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -113.61635842196267%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -20.951557598244598%
Free cash flow margin: -85.04986510995442%
Revenue growth: 33.85035532974408%
Rule of 40 score: -51.19950978021034
Market cap: 132544543.5 (Micro Cap ($50M-$300M))
Debt to equity: 1.2490303679528805
Free cash flow (dilution adjusted): -27040476
Operating income: -27730970
Net income: -69590462
Long score: 0 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for GEM.OL (quarterly, report date 2025-06-30)
Altman Z-score: 42.201429846417994 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.80747829957712%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.6402779359835973%
Rule of 40 score: 0
Market cap: 68684759.99999999 (Micro Cap ($50M-$300M))
P/E ratio: 79.49624999999999
Debt to equity: 0
Free cash flow (dilution adjusted): 595.8291956305859
Operating income: 14299.900695134062
Net income: 21449.85104270109
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for HYPD (annual, report date 2025-12-31)
Altman Z-score: -4.637113773217126 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1098.903386721085%
Capitalized R&D asset: 15882478.3
ROCI (R&D adjusted): -42.554604558170745%
Rosenberg metric: 0.24867523485551338
Free cash flow margin: -311163.0684262298%
Revenue growth: -47.81849100041858%
Rule of 40 score: -311210.8869172302
Market cap: 53961579.32 (Micro Cap ($50M-$300M))
Debt to equity: 0.20737062501444514
Free cash flow (dilution adjusted): -93096225
Operating income: -19764830.21
Net income: -45314435
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for MCF.V (annual, report date 2025-12-31)
Altman Z-score: -2.2454294594996664 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -103.89814054215518%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -16.799833252275413%
Rule of 40 score: 0
Market cap: 12388472.160000002 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -1783941.605839416
Operating income: -1764963.503649635
Net income: -10155474.452554744
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MCN (annual, report date 2024-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.802041803773516%
Capitalized R&D asset: 0
Revenue growth: -63.62962146075868%
Rule of 40 score: -63.62962146075868
Market cap: 117773366.7 (Micro Cap ($50M-$300M))
P/E ratio: 22.266275393642584
Debt to equity: 0
Net income: 5289316
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for NKL.V (annual, report date 2026-01-31)
Altman Z-score: 1.3171933787630723 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.3190012105004434%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.9743646575600393%
Rule of 40 score: 0
Market cap: 86057221 (Micro Cap ($50M-$300M))
Debt to equity: 0.39621962390915366
Free cash flow (dilution adjusted): -480134.8148148148
Operating income: -820468.1481481481
Net income: -785919.2592592592
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for PAG (annual, report date 2025-12-31)
Altman Z-score: 3.009971162744624 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 22.539995424065893%
Earnings yield: 5.436323347861102%
Return on net tangible assets: 41.43184713375796%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.315003622356121%
Free cash flow margin: 1.9501076756212963%
Revenue growth: -0.17668398985714645%
Rule of 40 score: 1.7734236857641499
Market cap: 10228611600.35 (Large Cap ($10B-$200B))
P/E ratio: 10.905865870935067
Debt to equity: 1.5627049400634305
Free cash flow (dilution adjusted): 620300000
Operating income: 1280700000
Net income: 937900000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for QLYS (annual, report date 2025-12-31)
Altman Z-score: 6.53483739074385 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 85.54876756152557%
Earnings yield: 5.018681419313206%
Return on net tangible assets: 37.8233909848194%
Capitalized R&D asset: 228680600
ROCI (R&D adjusted): 26.392702552023707%
Rosenberg metric: 0.520938382863069
Free cash flow margin: 33.99125723893144%
Revenue growth: 10.131161625554872%
Rule of 40 score: 44.12241886448631
Market cap: 4680340230.3 (Mid Cap ($2B-$10B))
P/E ratio: 23.599940652985076
Debt to equity: 0.09315462984248503
Free cash flow (dilution adjusted): 227444000
Operating income: 221952000
Net income: 198320000
Long score: 17 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for USIM5.SA (annual, report date 2025-12-31)
Altman Z-score: 1.3751227821777803 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 2.639710075141143%
Earnings yield: 0.8333846289669622%
Return on net tangible assets: -13.973526436994375%
Capitalized R&D asset: 4046309.385113269
ROCI (R&D adjusted): 1.8762405152515755%
Rosenberg metric: 50.91060314777549
Free cash flow margin: 3.840253279748091%
Revenue growth: 14.489757943130696%
Rule of 40 score: 18.330011222878788
Market cap: 3091604149.840934 (Mid Cap ($2B-$10B))
Debt to equity: 0.298071492121071
Free cash flow (dilution adjusted): 184047992.7007299
Operating income: 111499999.99999999
Net income: -531028102.189781
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for SBUX.TO (annual, report date 2025-09-30)
Piotroski F-score: 5 (Neutral)
Return on capital: 23.90211666700042%
Earnings yield: 2.0076167836123684%
Return on net tangible assets: -11.37092406488829%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.41868377251906%
Free cash flow margin: 5.711266014780392%
Revenue growth: -0.17098168480655238%
Rule of 40 score: 5.54028432997384
Market cap:  (Unknown)
Debt to equity: -3.289756712653911
Free cash flow (dilution adjusted): 1527841726.6187053
Operating income: 2576115107.913669
Net income: 1335755395.6834533
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 0670.HK (quarterly, report date 2026-03-31)
Altman Z-score: -0.35364243445358057 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 1.430419234573537%
Earnings yield: 0.11968262626928111%
Return on net tangible assets: -19.265556461317498%
Capitalized R&D asset: 26483632.416787267
ROCI (R&D adjusted): 1.1858431758198023%
Rosenberg metric: 18.90914938092941
Free cash flow margin: -9.98111171073934%
Revenue growth: 11.977486059251904%
Rule of 40 score: 1.996374348512564
Market cap: 67809353728 (Large Cap ($10B-$200B))
P/E ratio: 2.262220327099706
Debt to equity: 4.723
Free cash flow (dilution adjusted): -535311143.27062225
Operating income: 299276410.9985528
Net income: 249059334.29811865
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for 0752.HK (annual, report date 2025-10-31)
Altman Z-score: 2.5909867401034186 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 24.087089280821367%
Earnings yield: 5.020709237792776%
Return on net tangible assets: 23.0533598217152%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.075196180073384%
Free cash flow margin: 3.9244908786588586%
Revenue growth: 13.919862835510399%
Rule of 40 score: 17.84435371416926
Market cap: 2848296448 (Mid Cap ($2B-$10B))
P/E ratio: 0.9387538799303504
Debt to equity: 0.34740000000000004
Free cash flow (dilution adjusted): 36404890.60489061
Operating income: 63696525.0965251
Net income: 56116859.71685972
Long score: 12 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 1425.HK (annual, report date 2025-12-31)
Altman Z-score: 5.769480681990125 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 20.208810877005686%
Earnings yield: 12.525283197238885%
Return on net tangible assets: 16.635676994180077%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.99610593916773%
Free cash flow margin: 13.412630431042563%
Revenue growth: 2.6141722153427938%
Rule of 40 score: 16.026802646385356
Market cap: 775000000 (Small Cap ($300M-$2B))
P/E ratio: 0.5734625271900335
Debt to equity: 0.0325
Free cash flow (dilution adjusted): 18939203.084832903
Operating income: 24817095.115681235
Net income: 21433033.419023134
Long score: 13 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 2158.T (annual, report date 2026-03-31)
Altman Z-score: 3.8817712602996113 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 704.3268268983466%
Earnings yield: 0.01714871234846253%
Return on net tangible assets: 53.36986802848095%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.724662769049873%
Free cash flow margin: -7.43411663672345%
Revenue growth: 17.300790379442503%
Rule of 40 score: 9.866673742719053
Market cap: 24684347392 (Large Cap ($10B-$200B))
P/E ratio: 0.3620142509031398
Debt to equity: 1.0471
Free cash flow (dilution adjusted): -3554904.904904905
Operating income: 4625581.8318318315
Net income: 3404929.92992993
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 2198.HK (annual, report date 2025-12-31)
Altman Z-score: 0.9202550912647238 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 10.428578121830704%
Earnings yield: 0.6883577736193845%
Return on net tangible assets: -1.6855126526149844%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.028418233564018%
Free cash flow margin: -3.6695564672020597%
Revenue growth: -1.666425241216107%
Rule of 40 score: -5.335981708418167
Market cap: 3922771968 (Mid Cap ($2B-$10B))
P/E ratio: 0.9530378080130416
Debt to equity: 2.2308000000000003
Free cash flow (dilution adjusted): -96814285.71428572
Operating income: 102387571.42857143
Net income: 58523285.71428572
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for 3315.T (annual, report date 2026-03-31)
Altman Z-score: 1.1207688125204012 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0.9068547550603089%
Earnings yield: 0.004324788449239889%
Return on net tangible assets: -4.89213272364873%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8500590318772138%
Free cash flow margin: 9.313242728645527%
Revenue growth: -13.632312457846307%
Rule of 40 score: -4.3190697292007805
Market cap: 27647170560 (Large Cap ($10B-$200B))
Debt to equity: 1.9335
Free cash flow (dilution adjusted): 53246996.996997
Operating income: 3828828.828828829
Net income: -48035535.53553554
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 6262.T (annual, report date 2026-03-31)
Altman Z-score: 2.4756771106503432 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 2.574765532315579%
Earnings yield: 0.05872437442646511%
Return on net tangible assets: 3.7513686708923877%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.4935968308325753%
Free cash flow margin: 9.901173097924506%
Revenue growth: -8.01820345026492%
Rule of 40 score: 1.8829696476595856
Market cap: 13191779328 (Large Cap ($10B-$200B))
P/E ratio: 0.35493133072558186
Debt to equity: 0.1837
Free cash flow (dilution adjusted): 13415809.55955956
Operating income: 5923398.398398398
Net income: 2902427.4274274274
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for GKSL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 14.60054459500427 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 4.182081979492032%
Earnings yield: 0.00656763835430511%
Return on net tangible assets: 4.047469373550888%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.7754470490132492%
Revenue growth: 25.14488554597149%
Rule of 40 score: 25.14488554597149
Market cap: 10107704320 (Large Cap ($10B-$200B))
P/E ratio: 0.42940277675377597
Debt to equity: 0.1143
Operating income: 507693.9381093684
Net income: 534325.9855871132
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for GKSL.NS (annual, report date 2026-03-31)
Altman Z-score: 14.966822346650554 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 19.41526277470393%
Earnings yield: 0.0304901781178249%
Return on net tangible assets: -29.857071419785253%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.242490503103864%
Free cash flow margin: -191.7700034384625%
Revenue growth: 84.75044555439479%
Rule of 40 score: -107.01955788406772
Market cap: 10107704320 (Large Cap ($10B-$200B))
P/E ratio: 0.42940277675377597
Debt to equity: 0.1143
Free cash flow (dilution adjusted): -16667772.361169988
Operating income: 2356962.6960576517
Net income: 1781665.960152607
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for GOAU4.SA (quarterly, report date 2026-03-31)
Altman Z-score: 0.8373722144337733 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 3.534703265906633%
Earnings yield: 0.5929038602601551%
Return on net tangible assets: 27.855355158261357%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.5121987251564724%
Free cash flow margin: 8.759007496024239%
Revenue growth: 2.5950527115379085%
Rule of 40 score: 11.354060207562148
Market cap: 13506548736 (Large Cap ($10B-$200B))
P/E ratio: 4.352070701880589
Debt to equity: 0.2899
Free cash flow (dilution adjusted): 278350950.57034224
Operating income: 337905133.07984793
Net income: 192355513.3079848
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for GSI.V (quarterly, report date 2026-05-31)
Altman Z-score: 28.856961198234263 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 5.633343882106635%
Earnings yield: 0.8872069414177283%
Return on net tangible assets: 6.050372676043655%
Capitalized R&D asset: 1483181.777306524
ROCI (R&D adjusted): 5.170675114326364%
Rosenberg metric: 2.2796850862318143
Free cash flow margin: -48.21235747396428%
Revenue growth: 19.962218511013706%
Rule of 40 score: -28.250138962950576
Market cap: 184422048 (Micro Cap ($50M-$300M))
P/E ratio: 14.460613356429498
Debt to equity: 0.0125
Free cash flow (dilution adjusted): -4381400
Operating income: 1584026.086956522
Net income: 1698004.3478260871
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for INCR (annual, report date 2025-12-31)
Altman Z-score: 0.3215883779736997 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 3.2813010190406104%
Earnings yield: 2.158681825900108%
Return on net tangible assets: -12.468913714056923%
Capitalized R&D asset: 234006.1957277638
ROCI (R&D adjusted): 1.4172185543520246%
Rosenberg metric: 18.96644942727796
Free cash flow margin: 4.020355292376018%
Revenue growth: 29.847901411286042%
Rule of 40 score: 33.86825670366206
Market cap: 55209216 (Micro Cap ($50M-$300M))
Debt to equity: 0.4617
Free cash flow (dilution adjusted): 3416037.7358490564
Operating income: 2117295.5974842766
Net income: -11229559.748427672
Long score: 5 | Short score: 5
Recommendation: Neutral